» Authors » Chang-Han Lee

Chang-Han Lee

Explore the profile of Chang-Han Lee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 700
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee H, Lee S, Hong J, Yoo H, Jeong J, Kim Y, et al.
Small Methods . 2024 Sep; :e2401016. PMID: 39258379
Chimeric antigen receptor (CAR)-T cell therapy has revolutionized cancer treatment. CARs are activated at the immunological synapse (IS) when their single-chain variable fragment (scFv) domain engages with an antigen, allowing...
2.
Kim M, Bai X, Im H, Yang J, Kim Y, Kim M, et al.
Korean J Physiol Pharmacol . 2024 Aug; 28(5):457-467. PMID: 39198226
Nanobodies derived from camelids and sharks offer unique advantages in therapeutic applications due to their ability to bind to epitopes that were previously inaccessible. Traditional methods of nanobody development face...
3.
Kang C, Kim Y, Jo H, Lee C, Kim N, Lee C, et al.
Jpn J Infect Dis . 2024 Apr; 77(5):285-288. PMID: 38684427
The accurate identification of individuals without prior infection with severe acute respiratory syndrome coronavirus 2 is pivotal for seroepidemiological studies and vaccine trials. Owing to widespread vaccination against coronavirus disease...
4.
Lim W, Lee C, Lee C
Materials (Basel) . 2024 Apr; 17(3). PMID: 38591386
Sr ions in an aqueous solution were removed using Na-A zeolites synthesized from kaolin, a natural mineral. Na-A zeolites with high crystallinity were synthesized using NaOH/kaolin mass ratios of 0.6...
5.
Hwang S, Kim C, Jang Y, Lee C, Oh M, Kim K, et al.
Medicina (Kaunas) . 2024 Mar; 60(3). PMID: 38541188
Musculoskeletal (MSK) pain significantly impacts physical activity and quality of life in older adults, potentially influencing mortality. This study explored the relationship between MSK pain, physical activity, muscle mass, and...
6.
Lee C, Kim M, Park S, Kang C, Choe P, Kim N, et al.
Infect Dis (Lond) . 2023 Nov; 56(2):116-127. PMID: 37916860
The clinical outcomes and immunological features of coronavirus disease 2019 (COVID-19) patients receiving B-cell depletion therapy (BCDT), especially in Omicron variant era, have not been fully elucidated. We aimed to...
7.
Kim I, Kang C, Lee S, Lee C, Kim M, Seo C, et al.
J Med Virol . 2023 Nov; 95(11):e29199. PMID: 37916645
Despite the importance of antigen-specific T cells in infectious disease, characterizing and tracking clonally amplified T cells during the progression of a patient's symptoms remain unclear. Here, we performed a...
8.
Lee C, Choe P, Kang C, Lee E, Song K, Bang J, et al.
Front Immunol . 2023 Apr; 14:1106664. PMID: 37033936
Background: Little is known about the immune determinants for severe coronavirus disease 2019 (COVID-19) in individuals vaccinated against severe acute respiratory syndrome coronavirus 2. We therefore attempted to identify differences...
9.
Kang C, Kim M, Park S, Kim Y, Lee C, Choe P, et al.
J Med Virol . 2023 Feb; 95(2):e28558. PMID: 36755360
The fourth vaccination dose confers additional protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in individuals with no prior coronavirus disease-19 (COVID-19). However, its immunological benefit against...
10.
Kong C, Yang E, Shin J, Park J, Kim S, Park S, et al.
Transl Neurodegener . 2022 Dec; 11(1):57. PMID: 36575534
Background: Aducanumab (Adu), which is a human IgG1 monoclonal antibody that targets oligomer and fibril forms of beta-amyloid, has been reported to reduce amyloid pathology and improve impaired cognition after...